Searched for
SUN PHARMA HALOL
Organon gives Sun Pharma scale and reach, but challenge lies in integration, executionSun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It ...- Sun Pharma shares in focus after US FDA issues eight observations for Halol facilitySun Pharma shares will be in focus after the US FDA issued eight observations for its Halol facility following a GMP inspection. The plant ...
- USFDA pulls up Sun Pharma for lapses in Halol plant"This warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceutica...
- US FDA issues import alert on Sun Pharma's Halol facilitySun Pharma on Thursday said the US Food and Drug Administration (USFDA) has imposed an import alert on its Halol manufacturing site in Guja...
- US FDA lists Sun Pharma's Halol unit under 'import alert'The United States Food and Drug Administration (US FDA) has placed Sun Pharmaceuticals' Halol unit under 'import alert'. This implies that ...
- Sun Pharma drops 3% as USFDA initiates action against Halol facilityUSFDA inspected the facility from December 3 to December 13 and had issued eight observations, the company had earlier said in a regulatory...
- USFDA conducts inspection of Sun Pharma’s Halol site: SourcesThe USFDA inspection at Halol in 2015 had resulted in 23 observations – a set of deficiencies in the manufacturing processes.
- If Sun Pharma inspections come through, 2018 could be a turning point for Indian pharma: Amit Rajan, Prosfora Technology“We have to get our things in order for sterile manufacturing and Sun Pharma Halol plant is mostly on steriles.”
- US FDA may inspect Sun Pharma’s Halol site in February: SourcesEarlier in September 2014, the Halol site came under the lens, receiving as many as 23 observations from the US agency.The inspection culmi...
- USFDA subjects SPARC Xelpros nod to 'satisfactory resolution'Earlier this month, Sun Pharma said the US health regulator had made nine observations after the completion of inspection of its Halol faci...
- USFDA report on Halol unit to be positive in long-term: SunThe company's Halol facility recently underwent an inspection by the US Food and Drug Administration (USFDA).
- USFDA made 9 observations post Halol unit inspection: Sun PharmaThe United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Ph...
- Sun Pharma shares set to extend losses for fourth day on rising concern over Halol facilityETNow on Tuesday reported that the USFDA has informed that the Halol facility has issued a 14-page Form 483 post inspection.
- For Sun Pharma, a lot rides on USFDA's report on Halol PlantThe Sun Pharma stock has appreciated 13% since the announcement of its second quarter performance on November 10.
- Sun Pharma Halol site being inspected by US FDA: SourcesOver its recent call with investors, Sun Pharma management had maintained that the remediation exercise at the site have been completed and...
- Expect delay in start of royalty from 2 new drugs: SPARCSun Pharma Advanced Research Company (SPARC) expects further delay in start of royalty income from its two new drug applications, including...
- 5 global brokerages slash Sun Pharma targetsTop brokerages have scaled down their 12-month target price and EPS estimates for Sun Pharma, after the firm received a warning letter from...
- Sun Pharma gets warning letter from US FDA for its Halol siteSun Pharmaceutical Industries today said it has received a warning letter from the USFDA over violation of manufacturing norms in its facil...
- USFDA decision not a big setback, fundamentals intact: Sudipbandyopadhyay on Sun PharmaMonday's downfall has got to do with the US FDA revoking permission for that seizure drug of Sun Pharma, says Sudipbandyopadhyay.
- Sun Pharma ends 15% down; Jefferies, Macquarie maintain buy on despite profit warningGlobal brokerage firms maintain their positive views on Sun Pharmaceuticals, despite the company's profit warning for FY16.
Load More
